American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
-
Am J Health Syst Pharm · Mar 2007
Potential for airborne contamination in turbulent- and unidirectional-airflow compounding aseptic isolators.
The ability of turbulent- and unidirectional-airflow compounding aseptic isolators (CAIs) to control airborne contamination during aseptic compounding of compounded sterile preparations (CSPs) was studied. ⋯ The performance of four unidirectional-flow CAIs supports their use in pharmacy and nursing CSP operations, whereas the performance of one turbulent-flow CAI does not.
-
The advantages and disadvantages of intravenous patient-controlled analgesia (i.v. PCA) and epidural analgesia are discussed. New approaches to the management of patients with acute post-operative pain are described. The results of controlled clinical trials with these modalities are presented. ⋯ Recently approved agents and those in development may address a variety of unmet needs in the management of patients with post-operative pain.
-
Am J Health Syst Pharm · Mar 2007
Stability of an extemporaneously prepared alcohol-free phenobarbital suspension.
The physical and chemical short-term stability of alcohol-free, oral suspensions of phenobarbital 10 mg/mL prepared from commercially available tablets in both a sugar and a sugar-free vehicle was assessed at room temperature. ⋯ An extemporaneously prepared alcohol-free suspension of phenobarbital 10 mg/mL in a 1:1 mixture of Ora-Plus and Ora-Sweet or Ora-Sweet SF was stable for at least 115 days when stored in 2-oz amber plastic bottles at room temperature.
-
Am J Health Syst Pharm · Mar 2007
ReviewDietary supplements in patients with cancer: risks and key concepts, part 2.
The risks and key concepts regarding the use of dietary supplements in patients with cancer are described. ⋯ Counseling patients with cancer about dietary supplements requires a systematic thought process that considers the available theories and data, as well as the patients' views about the agents.